根据不少作者的统计分析，贲门癌患者术后５年生存率仅在２０％左右。为寻求提高其远期生存率的途径，采用术前短期服用氟脲嘧啶多相脂质体（ＦｌｕｏｒｏｕｒａｃｉｌｉＰｏｌｙｐｈａｓｅＬｉｐｏｓｏｍｅＣｏｍｐｏｓｉｔａＰｒｏＯｒａｌｅ—ＦＰＬＣ）进行探讨。１材... According to the statistical analysis of many authors, the postoperative 5-year survival rate of cardiac cancer patients is only about 20%. To seek ways to improve its long-term survival rate, short-term fluorouracil polyphase liposome composite (FPLC) was explored before surgery. 1 material...